1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Autoimmune Drug Focus JULY 2015

Autoimmune Drug Focus JULY 2015

  • July 2015
  • -
  • Espicom Business Intelligence
  • -
  • 24 pages

Industry Trend Analysis - Actemra/RoActemra Sales Will Overtake MabThera/Rituxan In Roche's Immunology Portfolio In FY15
Industry Brief - Novo Nordisk To Cease Tresiba's Distribution In Germany
Industry Brief - Levemir Receives Positive CHMP Opinion For Use In Children As Young As One
Industry Brief - Perle Reports Enrolment In Insulin Independence Phase III Trial
Industry Trend Analysis - Next-Generation Insulin Patch In The Making
Industry Brief - Sanofi's Lantus XR Approved In Japan
Industry Brief - First Patient Dosed In Midaform Insulin PharmFilm Phase IIa Study
Industry Brief - Immune Pharmaceuticals Initiates Bertilimumab Phase II Trials In UC/Bullous Pemphigoid
Industry Brief - RedHill Granted US Patent Allowances Covering RHB-104 Phase III CD Programme
Industry Brief - Qu Biologics Begins Phase II Trial In UC
Industry Brief - RedHill's RHB-104 Phase III CD Study Granted Clearance In Australia/New Zealand
Industry Brief - Tillotts To Acquire Ex-US Global Rights For Entocort From AstraZeneca
Industry Trend Analysis - Entocort Acquisition Will Improve Tillotts' Acquisition Profile
Industry Trend Analysis - Ovasave's Success Depends On Improving Existing CD Treatments
Industry Brief - TxCell's Ovasave Gains FDA Fast Track Designation For CD
Industry Trend Analysis - Genentech's Ocrelizumab Will Be Used In Second-Line MS
Industry Brief - Ablynx/Taisho Sign Japanese Ozoralizumab Licensing Deal For RA
Industry Brief - Teva/Active Biotech Report Completion Of Patient Enrolment In Laquinimod Phase III Trial
Industry Brief - Simponi Receives EC Approval For Nr-Axial SpA
Industry Brief - Novartis' Cosentyx Shows Sustained Efficacy Over One Year In PsA Patients
Industry Brief - FDA Accepts Xeljanz NDA For Moderate-To-Severe RA
Industry Brief - MTP Files Application For Partial Change In Dosage/Usage Of Remicade In Psoriasis
Industry Trend Analysis - Remsima On Course To Be A Global Biosimilar
Industry Brief - KHK Reports Results From KHK4827 Japanese Phase III Studies In Psoriasis
Industry Brief - Adcetris Phase II Trial Initiated In Lupus
Industry Brief - Gevokizumab Phase III Trial In Behçet's disease Misses Primary Endpoint
Industry Brief - Epratuzumab Phase III Trial Programme In SLE Misses Primary Endpoints
Industry Brief - Biogen Plans New Production Plant In Switzerland
Industry Trend Analysis - Receptos Acquisition Will Enhance Celgene's Blockbuster Autoimmune Expectations
Industry Trend Analysis - M&A Activity Ahead For Biogen
Industry Brief - Eisai To Transfer North Carolina Plant To Biogen
Industry Brief - Autoimmune Conferences - October 2015

Table Of Contents

Autoimmune Drug Focus JULY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Europe Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK

2016 Europe Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK

  • $ 12800
  • Industry report
  • September 2016
  • by Venture Planning Group

Complete report $19,700.  DataPack (test volumes, sales forecasts, supplier shares) $12,800. VPGMarketResearch’s new report is a study of the major business opportunities emerging in the European cance ...

R&D Drug Pipeline Database: 1-Year Subscription

R&D Drug Pipeline Database: 1-Year Subscription

  • $ 6600
  • Industry report
  • November 2016
  • by La Merie Publishing

R&D Drug Pipeline Database: 1-Year Subscription Subscription to La Merie Publishing’s proprietary R&D Drug Pieline Database provides 24/7 online access to information about more than 21,000 project entries ...

Cancer Vaccines: Technologies and Global Markets

Cancer Vaccines: Technologies and Global Markets

  • $ 6650
  • Industry report
  • November 2016
  • by BCC Research

This cancer vaccines report by BCC Research explores present and future strategies within the market which includes prophylactic vaccines and therapeutic vaccines. Use this report to: - Analyze the global ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.